Zidovudine: all 219 studies that test it
Page 3 of 3. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's SarcomaCompletedNCT00000687Phase 2
- A Study of Zidovudine in HIV-Infected Patients With Kidney ProblemsWithdrawnNCT00000685Phase 1
- A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002CompletedNCT00000682Phase 3
- (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARCCompletedNCT00000679Phase 2
- Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.CompletedNCT00000678Phase 2
- A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine TreatmentCompletedNCT00000671Phase 2
- Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four WeeksCompletedNCT00000670Not applicable
- Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00000664Phase 1
- A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV DiseaseCompletedNCT00000662Not applicable
- The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected PatientCompletedNCT00000661Phase 1
- Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia ComplexCompletedNCT00000657Phase 2
- A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV DiseaseCompletedNCT00000656Phase 1
- A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV InfectionCompletedNCT00000652Phase 1
- A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV TherapyCompletedNCT00000651Phase 3
- An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)CompletedNCT00000649Phase 1
- An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV InfectionCompletedNCT00000647Not applicable
- A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected ChildrenCompletedNCT00000637Phase 3
- The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.CompletedNCT00000629Phase 1
- A Pharmacokinetic Study of L-697,661 Alone and in Combination With ZidovudineCompletedNCT00000628Phase 1